Brivaracetam Tablet, Film Coated
Product Images NDC 73190-077

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 73190-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (074 60)

Packaging label for Brivaracetam Tablets 25 mg film-coated oral tablets by AvKARE. The label indicates a 60-tablet count and includes storage instructions, manufacturer information (MSN Pharmaceuticals Inc., Piscataway, NJ), and a barcode. It also instructs pharmacists to dispense a medication guide with the product.*

FDA Label Image

1 (075 60)

Brivaracetam Tablets 50 mg film-coated oral tablets by AvKARE. The label indicates 60 tablets per bottle. The label includes dosage form, active ingredient strength, storage instructions, manufacturer information, and a barcode.*

FDA Label Image

1 (076 60)

Brivaracetam 75 mg film-coated tablets oral packaging label by AvKARE. The label shows 60 tablets in the package, includes dosage strength, storage instructions, and manufacturer details (MSN Pharmaceuticals Inc.). It also instructs pharmacists to dispense the Medication Guide with each prescription.*

FDA Label Image

1 (077 60)

Label for Brivaracetam Tablets 100 mg film-coated tablets by AvKARE. The label includes dosage instructions, storage conditions, manufacturer details (MSN Pharmaceuticals Inc., Piscataway, NJ), and a barcode. The package contains 60 tablets and indicates prescription use (Rx Only).*

FDA Label Image

Brivaracetam-figure-1 (Brivaracetam Figure 1)

A bar chart showing the proportion of patients (%) in different categories of seizure frequency reduction from baseline. Categories range from 'Worse' to '75 to 100%' reduction, comparing placebo and brivaracetam doses of 50 mg/day, 100 mg/day, and 200 mg/day. The chart includes sample sizes for each group.*

FDA Label Image

Brivaracetam-structure (Brivaracetam Structure)

Chemical structure of brivaracetam, showing its molecular configuration with characteristic functional groups and stereochemistry as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.